Company: BDRX
Filing Date: 2025-01-17
Form Type: F-1
Source: 0001214659-25-000922
Chunk: 428

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-17
Form: F-1
Chunk 428
---
2024, by and between Biodexa Pharmaceuticals PLC and the investors identified on the signature pages thereto (incorporated by reference to Exhibit 10.1 of the Company’s Report on Form 6-K, filed with the SEC on July 19, 2024). |
| 10.27  | Placement Agency Agreement, dated July 18, 2024, by and between Biodexa Pharmaceuticals PLC and Ladenburg Thalmann & Co. Inc. (incorporated by reference to Exhibit 10.2 of the Company’s Report on Form 6-K, filed with the SEC on July 19, 2024).                                      |
| 10.28  | Promissory Note issued to C/M Capital Master Fund, LP, dated as of December 20, 2024 (incorporated by reference to Exhibit 10.1 to the Company’s Report on Form 6-K, filed with the SEC on December 27, 2024).                                                                           |
| 10.29  | Securities Purchase Agreement, dated January 15, 2025, by and between C/M Capital Master Fund, LP, and Biodexa Pharmaceuticals PLC (incorporated by reference to Exhibit 10.1 to the Company’s Report on Form 6-K, filed with the SEC on January 17, 2025).                              |
| 10.30  | Registration Rights Agreement, dated January 15, 2025, by and between C/M Capital Master Fund, LP, and Biodexa Pharmaceuticals PLC (incorporated by reference to Exhibit 10.2 to the Company’s Report on Form 6-K, filed with the SEC on January 17, 2025).                              |
| 21.1*  | Subsidiaries of Biodexa Pharmaceuticals PLC.                                                                                                                                                                                                                                             |
| 23.1*  | Consent of Forvis Mazars LLP, independent registered public accounting firm.                                                                                                                                                                                                             |
| 23.2*  | Consent of Brown Rudnick LLP (included in Exhibit 5.1).                                                                                                                                                                                                                                  |
| 24.1*  | Powers of Attorney (included on signature page).                                                                                                                                                                                                                                         |
| 107*   | Filing Fee Table.                                                                                                                                                                                                                                                                        |

__

* Filed herewith.

| 

# | Management contract or compensatory plan or arrangement. |
| † | Certain portions of this exhibit (indicated by asterisks) have been omitted because they are